Background*

Dr. Rosina B. Dixon, M.D. has been the Senior Director of Global Pharmacovigilance and Epidemiology at Sanofi-Aventis, Bridgewater, NJ since September 2006. Dr. Dixon served as Consultant to the pharmaceutical industry from May 1986 to September 2006. she served as a Vice President and Secretary of Medical Market Specialties Inc. Prior to 1986, she held senior positions at Ciba-Geigy Pharmaceuticals, a division of Ciba-Geigy Corp., and Schering-Plough Corp. Dr. Dixon ... served as Medical Director of Schering Laboratories and Schering-Plough Corp. She has been a Director of Cambrex Corporartion since 1995. She serves as a Director of Daytop NJ, a residential substance abuse facility. She served as a Director of Enzon Pharmaceuticals Inc. (formerly Enzon Inc.) from August 1994 to April 30, 2006. She served as a Director of Church & Dwight Co. Inc. from 1979 to May 1, 2014. She served as a Director of Medical Market Specialties Inc. and as Executive Director of Biodevelopment and Pharmaceuticals Division of CIBA-GEIGY Corp. Dr. Dixon also serves on the Board of Advisors for the Silberman College of Business at Fairleigh Dickinson College. She is a Member of the American College of Clinical Pharmacology, American Society for Clinical Pharmacology and Therapeutics, and the National Association of Corporate Directors. She received her M.D. from Columbia University, College of Physicians and Surgeons and is certified by the National Board of Medical Examiners and the American Board of Internal Medicine.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.